New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs

NIH-funded study focuses on severe forms of relapsing MS. A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will compare the safety, efficacy and cost-effectiveness of the two therapeutic approaches. MS is an autoimmune disease in which a person’s own […]

Fetal surgery benefits to repair spina bifida persist through school age

Children as young as 6 years old who underwent fetal surgery to repair a common birth defect of the spine are more likely to walk independently and have fewer follow-up surgeries, compared to those who had traditional corrective surgery after birth, according to researchers funded by the National Institutes of Health. The study appears in Pediatrics. The procedure corrects myelomeningocele, the most serious form of spina bifida, a condition in which the spinal column fails […]

What is the Newborn Screening Clearinghouse?

Baby’s First Test houses the nation’s newborn screening clearinghouse. The clearinghouse provides current educational and family support and services information, materials, and resources about newborn screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information. The clearinghouse is supported and funded as a result of the Newborn Screening Saves Lives Act passed in 2008. Continued support for the clearinghouse is possible under the Newborn Screening Saves Lives Reauthorization […]

Autism symptoms severity varies greatly among identical twins

Findings from NIH-funded study could inform treatment strategies. WHAT: Identical twins with autism spectrum disorder (ASD) often experience large differences in symptom severity even though they share the same DNA, according to an analysis funded by the National Institutes of Health. The findings suggest that identifying the causes of this variability may inform the treatment of ASD-related symptoms. The study was conducted by John Constantino, M.D., of Washington University School of Medicine in St. Louis, […]

Three anti-seizure drugs equally effective for severe form of epilepsy

NIH-funded research shows no difference in efficacy or adverse effects of commonly used treatments. There are three treatment options commonly used by doctors in the emergency room to treat patients with refractory status epilepticus, severe seizures that continue even after benzodiazepine medications, which are effective in controlling seizures in more than two-thirds of patients. New findings published in the New England Journal of Medicine reveal that the three drugs, levetiracetam, fosphenytoin, and valproate, are equally […]